- AU$3.30m
- AU$3.65m
- AU$5.52m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.91 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.45 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -57.31% | ||
| Return on Equity | -79.81% | ||
| Operating Margin | -43.51% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | 0.15 | 0.74 | 4.43 | 5.52 | n/a | n/a | 234.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Careteq Limited is an Australia-based health-tech company, which has developed and commercialized an Assistive Living Technology platform. The Company is using its early-mover advantage in the Assistive Living Technology sector to revolutionize aged and disability care across the globe. Its brands include Sofihub, TEQ-FallsAlert and Embedded Health Solutions (EHS). The Sofihub brand is an advanced adaptive care technology that gives people of all ages and abilities the freedom to live independently, while reducing their reliance on family or professional careers. Sofihub has developed a suite of intelligent adaptive technology that enables the aged and at-risk members of society to live independently. TEQ-FallsAlert powered by Sofihub employs radar technology that provides continuous non-invasive monitoring, allowing care resources to be managed efficiently. EHS helps health care workers with professional knowledge and advice to help prevent incidents of medicine-related harm.
Directors
- Mark Simari NEC (50)
- Peter Scala CEO
- David Lilja CFO
- Alexander Boyd COO
- Brett Cheong NID (59)
- Stephen Munday NID (54)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 7th, 2016
- Public Since
- January 10th, 2022
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 235,547,292
- Address
- Level 10, 99 Queen St, MELBOURNE, 3000
- Web
- https://www.careteq.com.au/
- Phone
- +61 388665594
- Auditors
- RSM Australia Partners
Upcoming Events for CTQ
Similar to CTQ
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Capitol Health
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:04 UTC, shares in Careteq are trading at AU$0.01. This share price information is delayed by 15 minutes.
Shares in Careteq last closed at AU$0.01 and the price had moved by -74.55% over the past 365 days. In terms of relative price strength the Careteq share price has underperformed the ASX All Ordinaries Index by -75.65% over the past year.
There is no consensus recommendation for this security.
Careteq does not currently pay a dividend.
Careteq does not currently pay a dividend.
Careteq does not currently pay a dividend.
To buy shares in Careteq you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.01, shares in Careteq had a market capitalisation of AU$3.30m.
Here are the trading details for Careteq:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CTQ
Based on an overall assessment of its quality, value and momentum Careteq is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Careteq. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -45.83%.
As of the last closing price of AU$0.01, shares in Careteq were trading -58.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Careteq PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Careteq's management team is headed by:
- Mark Simari - NEC
- Peter Scala - CEO
- David Lilja - CFO
- Alexander Boyd - COO
- Brett Cheong - NID
- Stephen Munday - NID